Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Don't Sell Valeant Based on U.S. Attorney Probe: More Squawk From Jim Cramer

NEW YORK (TheStreet) -- Shares of Valeant Pharmaceuticals (VRX) were rebounding on Tuesday morning after the stock tumbled about 12% yesterday following a report that former CEO Michael Pearson and ex-CFO Howard Schiller are the subject of a U.S. criminal probe.

"if you want to sell Valeant, Valeant was down very badly yesterday, do not sell it off the U.S. attorney," TheStreet's Jim Cramer said on CNBC's "Squawk on the Street" this morning.

"You sell it off the $30 billion in debt...You sell it off the fact that every single drug stock has had a line of...


More